Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

Aptevo Therapeutics Inc. (Nasdaq: APVO)

Aptevo Therapeutics Inc. is a biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Our core technology is the ADAPTIR modular protein technology platform. Aptevo has four commercial products in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology. *


Period Start 2016-08-01 splitoff
  Group Aptevo Therapeutics (Group)
  Predecessor Emergent BioSolutions Inc. (EBSI) (NYSE: EBS)
Products Industry BIOTECH
  Industry 2 ADAPTIR™ (molecular protein technology) platform
Person Person White, Marvin L. (Aptevo Therapeutics 201707 CEO)
Region Region Seattle, WA
  Country United States (USA)
  Street 2401 4th Avenue
Suite 1050
  City 98121 Seattle, WA
  Tel +1-206-838-0500
    Address record changed: 2016-11-21
Basic data Employees D: 101 to 500 (2016-11-21)
    * Document for �About Section�: Alligator Bioscience AB. (7/21/17). "Press Release: Aptevo Therapeutics and Alligator Bioscience Announce Plans to Co-develop Novel Bispecific Antibody for Tumor-directed Immunotherapy". Seattle, WA & Lund.
Record changed: 2020-03-14


Picture [iito] Männer Ballett 650x80px

More documents for Aptevo Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top